Non–High-Density Lipoprotein Cholesterol Versus Apolipoprotein B in Cardiovascular Risk Stratification

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · see citing works

Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026 · see citing works

Prevalence and Trends in Obesity Among US Adults, 1999-2008

Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580 · see citing works

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992 · see citing works

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550 · see citing works

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866 · see citing works

Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association

WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700 · see citing works

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938 · see citing works

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Sever, P., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M. J., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,756 · see citing works

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489 · see citing works

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378 · see citing works

Major lipids, apolipoproteins, and risk of vascular disease

The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731 · see citing works

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction<SUBTITLE>The IDEAL Study: A Randomized Controlled Trial</SUBTITLE>

Pedersen, T. R. (2005) · JAMA · doi:10.1001/jama.294.19.2437 · Cited by 1,548 · see citing works

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

WRITING GROUP MEMBERS, Lloyd‐Jones, D. M., Adams, R. J., Brown, T. M., Carnethon, M. R., Dai, S., SIMONE, G. D., Ferguson, T. B., Ford, E. S., Furie, K. L., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192666 · Cited by 1,358 · see citing works

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

Walldius, G., Jungner, I., Holme, I., AASTVEIT, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,227 · see citing works

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

Genest, J. J., McPherson, R., Frohlich, J. J., Anderson, T. J., Campbell, N. R. C., Carpentier, A. C., Couture, P., Dufour, R., Fodor, G. J., Francis, G. A., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70715-9 · Cited by 758 · see citing works

Non–HDL Cholesterol, Apolipoproteins A-I and B ₁₀₀ , Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

Ridker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744 · see citing works

Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve

Cook, N. R. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.096529 · Cited by 691 · see citing works

Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality

Cui, Y. A., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., LANGENBERG, P. W., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 657 · see citing works

Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

Pedersen, T. R., OLSSON, A. G., Færgeman, O., KJEKSHUS, J. K., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T. H., Þorgeirsson, G., Pyörälà, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 618 · see citing works

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women

Ingelsson, E., Schaefer, E. J., Contois, J. H., McNamara, J. R., Sullivan, L., Keyes, M. J., Pencina, M. J., Schoonmaker, C., Wilson, P. W. F., D’Agostino, R. B., et al. (2007) · JAMA · doi:10.1001/jama.298.7.776 · Cited by 608 · see citing works

Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Gotto, A. M., Whitney, E. J., Stein, E. A., Shapiro, D. R., Clearfield, M. B., Weis, S. E., Jou, J. Y., Langendörfer, A., Beere, P. A., Watson, D. J., et al. (2000) · Circulation · doi:10.1161/01.cir.101.5.477 · Cited by 562 · see citing works

Lipoprotein Management in Patients With Cardiometabolic Risk

Brunzell, J. D., Davidson, M. H., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.034 · Cited by 523 · see citing works

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men

Pischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514 · see citing works

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.

Mora, S., Otvos, J. D., Rifai, N., Rosenson, R. S., Buring, J. E., & Ridker, P. M. (2009) · Circulation · doi:10.1161/circulationaha.108.816181 · Cited by 490 · see citing works

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment

Kastelein, J. J. P., van der Steeg, W. A., Holme, I., Gaffney, M., Cater, N. B., Barter, P., Deedwania, P., Olsson, A. G., Boekholdt, S. M., Demicco, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.713438 · Cited by 478 · see citing works

Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study

Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476 · see citing works

Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes

Lu, W., Resnick, H. E., Jablonski, K. A., Jones, K. L., Jain, A. K., Howard, W. J., Robbins, D. C., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.16 · Cited by 370 · see citing works

Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

Robinson, J. G., Wang, S., Smith, B. J., & Jacobson, T. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.024 · Cited by 368 · see citing works

Beyond Low-Density Lipoprotein Cholesterol

Arsenault, B. J., Rana, J. S., Stroes, E. S. G., Després, J.-P., Shah, P. K., Kastelein, J. J. P., Wareham, N. J., Boekholdt, S. M., & Khaw, K.-T. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.057 · Cited by 342 · see citing works

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

Contois, J. H., McConnell, J. P., Sethi, A. A., Csako, G., Devaraj, S., Hoefner, D. M., & Warnick, G. R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118356 · Cited by 326 · see citing works

Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy

Grundy, S. M. (2002) · Circulation · doi:10.1161/01.cir.0000038419.53000.d6 · Cited by 309 · see citing works

Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study

Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., SHALAUROVA, I. Y., Cupples, L. A., Parise, H., D’Agostino, R. B., Wilson, P. W. F., & Schaefer, E. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032763 · Cited by 304 · see citing works

Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without Diabetes

Liu, J., Sempos, C. T., Donahue, R. P., Dorn, J. P., Trevisan, M., & Grundy, S. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1916 · Cited by 237 · see citing works

The importance of non–HDL cholesterol reporting in lipid management

Blaha, M. J., Blumenthal, R. S., Brinton, E. A., & Jacobson, T. A. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.06.013 · Cited by 193 · see citing works

Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Que´bec cardiovascular study)

Lamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80760-7 · Cited by 170 · see citing works

Non–High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI)

Bittner, V., Hardison, R., Kelsey, S. F., Weiner, B. H., Jacobs, A. K., & Sopko, G. (2002) · Circulation · doi:10.1161/01.cir.0000038496.57570.06 · Cited by 168 · see citing works

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

Ballantyne, C. M., Andrews, T. C., Hsia, J. A., Kramer, J. H., & Shear, C. L. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01638-1 · Cited by 166 · see citing works

Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events

van Lennep, J. E. R., Westerveld, H. T., van Lennep, H. W. O. R., Zwinderman, A. H., Erkelens, D. W., & van der Wall, E. E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2408 · Cited by 152 · see citing works

Serum Lipids and Incidence of Coronary Heart Disease

Frost, P. H., Davis, B. R., Burlando, A. J., Curb, J. D., Guthrie, G. P., Isaacsohn, J. L., Wassertheil-Smoller, S. W., Wilson, A. C., & Stamler, J. (1996) · Circulation · doi:10.1161/01.cir.94.10.2381 · Cited by 148 · see citing works

The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations

Scharnagl, H., Nauck, M. A., Wieland, H., & März, W. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.068 · Cited by 140 · see citing works

Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice

Sniderman, A. D. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.12.006 · Cited by 116 · see citing works

Population frequency distribution of non–high-density lipoprotein cholesterol (third national health and nutrition examination survey [NHANES iii], 1988–1994)

Gardner, C. D., Winkleby, M. A., & Fortmann, S. P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00918-8 · Cited by 95 · see citing works

Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals

Orakzai, S. H., Nasir, K., Blaha, M. J., Blumenthal, R. S., & Raggi, P. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.014 · Cited by 91 · see citing works

Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use

Mora, S. (2009) · Circulation · doi:10.1161/circulationaha.108.819359 · Cited by 89 · see citing works

Utility of Non–High-Density Lipoprotein Cholesterol Versus Other Lipoprotein Measures in Detecting Subclinical Atherosclerosis in Young Adults (The Bogalusa Heart Study)

Frontini, M., Srinivasan, S. R., Xu, J.-H., Tang, R., Bond, M. G., & Berenson, G. S. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.01.071 · Cited by 80 · see citing works

Lipid and Apolipoprotein Predictors of Atherosclerosis in Youth: Apolipoprotein Concentrations Do Not Materially Improve Prediction of Arterial Lesions in PDAY Subjects

Rainwater, D. L., McMahan, C. A., Malcom, G. T., Scheer, W. D., Roheim, P. S., McGill, H. C., & Strong, J. P. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.753 · Cited by 62 · see citing works

Assessment of Reaching Goal in Patients with Combined Hyperlipidemia: Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, or Apolipoprotein B

Stein, E. A., Sniderman, A. D., & Laskarzewski, P. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.006 · Cited by 58 · see citing works

Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men

Simon, A. C., Chironi, G. N., Gariépy, J., Pino, M. D., & Levenson, J. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.017 · Cited by 49 · see citing works

A novel complex deletion–insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency

Okubo, M., Horinishi, A., Saito, M., Ebara, T., Endo, Y., Kaku, K., Murase, T., & Eto, M. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.06.018 · Cited by 43 · see citing works

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target

Hoenig, M. R. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.143 · Cited by 33 · see citing works

Non–High-Density Lipoprotein Cholesterol: The Forgotten Therapeutic Target

Maki, K. C., Galant, R., & Davidson, M. H. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.009 · Cited by 28 · see citing works

Non-high-density lipoprotein cholesterol and cardiovascular disease

Bittner, V. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200308000-00005 · Cited by 20 · see citing works

Andrea del Sarto

Browning, R. (1855) · Oxford University Press eBooks · doi:10.1093/oseo/instance.00121904 · Cited by 19 · see citing works

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target

Hoenig, M. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2364 · Cited by 11 · see citing works

Metabolic syndrome update

Grundy, S. M. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.10.004 · Cited by 882 · see citing works

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 772 · see citing works

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary

Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.07.007 · Cited by 464 · see citing works

Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications

Martin, S. S., Blaha, M. J., Elshazly, M. B., Brinton, E. A., Toth, P. P., McEvoy, J. W., Joshi, P. H., Kulkarni, K. R., Mize, P. D., Kwiterovich, P. O., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.079 · Cited by 428 · see citing works

Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

Upadhyay, R. K. (2015) · Journal of Lipids · doi:10.1155/2015/971453 · Cited by 362 · see citing works

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia

Grundy, S. M. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 349 · see citing works

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report

Grundy, S. M., Arai, H., Barter, P. J., Bersot, T. P., Betteridge, D. J., Carmena, R., Cuevas, A. M., Davidson, M. H., Genest, J. J., Kesäniemi, Y. A., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.12.005 · Cited by 328 · see citing works

Effects of an isocaloric healthy N ordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome – a randomized study ( SYSDIET )

Uusitupa, M. I. J., Hermansen, K., Savolainen, M. J., Schwab, U., Kolehmainen, M., Brader, L., Mortensen, L. S., Cloetens, L., Johansson‐Persson, A., Önning, G., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12044 · Cited by 267 · see citing works

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262 · see citing works

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Langlois, M. R., Chapman, M. J., Cobbaert, C., Mora, S., Remaley, A. T., Ros, E., Watts, G. F., Borén, J., Baum, H., Bruckert, E., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287037 · Cited by 260 · see citing works

Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data From UK Biobank

Welsh, C., Celis-Morales, C. A., Brown, R., Mackay, D. F., Lewsey, J., Mark, P. B., Gray, S. R., Ferguson, L. D., Anderson, J. J., Lyall, D. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.041149 · Cited by 191 · see citing works

Triglyceride to HDL-C Ratio and Increased Arterial Stiffness in Children, Adolescents, and Young Adults

Urbina, E. M., Khoury, P. R., McCoy, C. E., Dolan, L. M., Daniels, S. R., & Kimball, T. R. (2013) · PEDIATRICS · doi:10.1542/peds.2012-1726 · Cited by 170 · see citing works

Health Coaching by Medical Assistants to Improve Control of Diabetes, Hypertension, and Hyperlipidemia in Low-Income Patients: A Randomized Controlled Trial

Willard-Grace, R., Chen, E. H., Hessler, D., DeVore, D., Prado, C., Bodenheimer, T., & Thom, D. H. (2015) · The Annals of Family Medicine · doi:10.1370/afm.1768 · Cited by 143 · see citing works

Untitled work

Robinson (2012) · doi:10.1016/j.amjcard.2012.07.007 · Cited by 137 · see citing works

High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol

Trajkovska, K. T. (2017) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.7608 · Cited by 133 · see citing works

National lipid association annual summary of clinical lipidology 2016

Bays, H. E., Jones, P. H., Orringer, C. E., Brown, W. V., & Jacobson, T. A. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.08.002 · Cited by 128 · see citing works

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline

Rosenzweig, J. L., Bakris, G. L., Berglund, L., Hivert, M., Horton, E. S., Kalyani, R. R., Murad, M. H., & Vergès, B. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01338 · Cited by 131 · see citing works

Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease

Orekhov, A. N., Bobryshev, Y. V., Sobenin, I. A., Melnichenko, A. А., & Chistiakov, D. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150712807 · Cited by 100 · see citing works

Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes

KONES, R. J. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s37119 · Cited by 89 · see citing works

Update on the NCEP ATP-III emerging cardiometabolic risk factors

Eckel, R. H., & Cornier, M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-115 · Cited by 90 · see citing works

Measuring LDL-cholesterol: what is the best way to do it?

Wolska, A. T., & Remaley, A. T. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000740 · Cited by 84 · see citing works

The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease

deGoma, E. M., Knowles, J. W., Angeli, F., Budoff, M. J., & Rader, D. J. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e318239b924 · Cited by 78 · see citing works

The effectiveness of medical assistant health coaching for low-income patients with uncontrolled diabetes, hypertension, and hyperlipidemia: protocol for a randomized controlled trial and baseline characteristics of the study population

Willard‐Grace, R., DeVore, D., Chen, E. H., Hessler, D., Bodenheimer, T. S., & Thom, D. H. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-27 · Cited by 74 · see citing works

Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol

Su, X., Kong, Y., & Peng, D. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1080-x · Cited by 72 · see citing works

Dyslipidemia

Mancini, G. B. J., Hegele, R. A., & Leiter, L. A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.019 · Cited by 70 · see citing works

LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker

Aggarwal, D. J., Kathariya, G., & Verma, P. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.07.013 · Cited by 69 · see citing works

How to control residual cardiovascular risk despite statin treatment: Focusing on HDL–cholesterol

Lim, S. K., Park, Y. M., Sakuma, I., & Koh, K. K. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.127 · Cited by 64 · see citing works

Cardiovascular risk

Payne, R. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04219.x · Cited by 67 · see citing works

The Role of Non-HDL Cholesterol in Risk Stratification for Coronary Artery Disease

Rana, J. S., Boekholdt, S. M., Kastelein, J. J. P., & Shah, P. K. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0224-x · Cited by 64 · see citing works

Non-HDL Cholesterol Levels in Childhood and Carotid Intima-Media Thickness in Adulthood

Juonala, M., Wu, F., Sinaiko, A. R., Woo, J. G., Urbina, E. M., Jacobs, D. R., Steinberger, J., Prineas, R. J., Koskinen, J. M., Sabin, M. A., et al. (2020) · PEDIATRICS · doi:10.1542/peds.2019-2114 · Cited by 63 · see citing works

Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk

Marston, N. A., Bergmark, B. A., Alexander, V. J., Prohaska, T. A., Kang, Y. M., Moura, F. A., Zimerman, A., Waldman, E., Weinland, J., Murphy, S. A., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2512761 · Cited by 62 · see citing works

Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women

Choi, Y., Chang, Y., Kim, B.-K., Kang, D., Kwon, M., Kim, C., Jeong, C., Ahn, Y., Park, H., Ryu, S., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2014.12.016 · Cited by 60 · see citing works

Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review

Sandhu, P. K., Musaad, S. M. A., Remaley, A. T., Buehler, S. S., Strider, S., Derzon, J. H., Vesper, H. W., Ranne, A., Shaw, C. S., & Christenson, R. H. (2016) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.021006 · Cited by 55 · see citing works

Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes.

Bosomworth, N. J. (2013) · Europe PMC (PubMed Central) · Cited by 54 · see citing works

Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes

Sone, H., Tanaka, S., Tanaka, S., Iimuro, S., Ishibashi, S., Oikawa, S., Shimano, H., Katayama, S., Ohashi, Y., Akanuma, Y., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1412 · Cited by 53 · see citing works

High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine

Reijnders, E., van der Laarse, A., Jukema, J. W., & Cobbaert, C. M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1264319 · Cited by 50 · see citing works

Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study

Saito, I., Yamagishi, K., Kokubo, Y., Yatsuya, H., Iso, H., Sawada, N., Inoue, M., & Tsugane, S. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.50385 · Cited by 46 · see citing works

Associations of non-high density lipoprotein cholesterol and traditional blood lipid profiles with hyperuricemia among middle-aged and elderly Chinese people: a community-based cross-sectional study

Xu, J., Peng, H. Y., Ma, Q., Zhou, X., Xu, W., Huang, L., Hu, J., & Zhang, Y. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-117 · Cited by 45 · see citing works

Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the Meantime, Some Challenges and Recommendations

Martin, S. S., Metkus, T. S., Horne, A., Blaha, M. J., Hasan, R. K., Campbell, C. Y., Yousuf, O. K., Joshi, P. H., Kaul, S., Miller, M. J., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.03.023 · Cited by 43 · see citing works

Discordance between non-HDL-cholesterol and LDL-particle measurements: Results from the Multi-Ethnic Study of Atherosclerosis

deGoma, E. M., Davis, M. D., Dunbar, R. L., Mohler, E. R., Greenland, P., & French, B. C. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.012 · Cited by 43 · see citing works

Global prevalence of dyslipidaemia in adult populations: a systematic review protocol

Mohamed-Yassin, M.-S., Baharudin, N., Abdul-Razak, S., Ramli, A. S., & Lai, N. M. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049662 · Cited by 44 · see citing works

Opening a New Lipid “Apo-thecary”: Incorporating Apolipoproteins as Potential Risk Factors and Treatment Targets to Reduce Cardiovascular Risk

Jacobson, T. A. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0128 · Cited by 42 · see citing works

Risks and benefits of phytoestrogens

Bennetau‐Pelissero, C. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000326 · Cited by 40 · see citing works

Dietary supplementation of soybean-derived sterols regulates cholesterol metabolism and intestinal microbiota in hamsters

Li, X., Zhang, Z., Cheng, J., Diao, C., Yan, Y., Liu, D., Wang, H., & Zheng, F. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.05.032 · Cited by 39 · see citing works

Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial

Stroes, E. S. G., Susekov, A. V., de Bruin, T. W. A., Kvarnström, M., Yang, H., & Davidson, M. H. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.10.012 · Cited by 38 · see citing works

Ursolic acid alleviates lipid accumulation by activating the AMPK signaling pathway in vivo and in vitro

Cheng, J., Liu, Y., Liu, Y., Liu, D., Liu, Y., Guo, Y., Wu, Z., Li, H., & Wang, H. (2020) · Journal of Food Science · doi:10.1111/1750-3841.15475 · Cited by 36 · see citing works

Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles

Xue, Y., Shen, J., Hong, W., Zhou, W., Xiang, Z., Zhu, Y., Huang, C., & Luo, S. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01475-z · Cited by 31 · see citing works

Non‐<scp>HDL</scp> cholesterol vs. Apo B for risk of coronary heart disease in healthy individuals: the <scp>EPIC</scp>‐Norfolk prospective population study

Sondermeijer, B. M., Rana, J. S., Arsenault, B. J., Shah, P. K., Kastelein, J. J. P., Wareham, N. J., Boekholdt, S. M., & Khaw, K. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12129 · Cited by 30 · see citing works

Plaque imaging to refine indications for emerging lipid-lowering drugs

Alkhalil, M., Chai, J. T., & Choudhury, R. P. (2016) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw034 · Cited by 30 · see citing works

Reference Ranges for the Non-High-Density Lipoprotein Cholesterol Levels in Japanese Children and Adolescents

Abe, Y., Okada, T., スギウラ, レ., Yamauchi, K., & Murata, M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.28100 · Cited by 29 · see citing works

High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome

Barkas, F., Elisaf, M., Liberopoulos, E. N., Liontos, A., & Rizos, E. C. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.001 · Cited by 28 · see citing works

Low-Density Lipoprotein Cholesterol versus Particle Number in Middle School Children

Mietus‐Snyder, M., Drews, K. L., Otvos, J. D., Willi, S. M., Foster, G. D., Jago, R., & Buse, J. B. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.01.012 · Cited by 28 · see citing works

Effects of Acute Cocoa Supplementation on Postprandial Apolipoproteins, Lipoprotein Subclasses, and Inflammatory Biomarkers in Adults with Type 2 Diabetes after a High-Fat Meal

Davis, D. W., Tallent, R., Navalta, J. W., Salazar, A., Lyons, T. J., & Basu, A. (2020) · Nutrients · doi:10.3390/nu12071902 · Cited by 30 · see citing works

Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study

Ndumele, C. E., Matsushita, K., Astor, B. C., Virani, S. S., Mora, S., Williams, E., Hoogeveen, R. C., Blumenthal, R. S., Sharrett, A. R., Ballantyne, C. M., et al. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312465523 · Cited by 27 · see citing works

Relevance of intermediate-density lipoprotein cholesterol to Framingham risk score of coronary heart disease in middle-aged men with increased non-HDL cholesterol

Ito, K., Yoshida, H., Yanai, H., Kurosawa, H., Sato, R., Manita, D., Hirowatari, Y., & Tada, N. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.023 · Cited by 27 · see citing works

What Is the Role of Advanced Lipoprotein Analysis in Practice?

Robinson, J. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.067 · Cited by 26 · see citing works

Current pharmacotherapeutic options for primary dyslipidemia in adults

Cicero, A. F. G., Landolfo, M., Ventura, F., & Borghi, C. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1604687 · Cited by 24 · see citing works

Prevalence and Incident Prehypertension and Hypertension in Postmenopausal Hispanic Women: Results from the Women's Health Initiative

Zambrana, R. E., López, L., Dinwiddie, G. Y., Ray, R. M., Phillips, L. S., Trevisan, M., & Wassertheil-Smoller, S. W. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpt279 · Cited by 24 · see citing works

Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway

Egeland, G. M., Igland, J., Sulo, G., Nygard, O. K., Ebbing, M., & Tell, G. S. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314535681 · Cited by 24 · see citing works

Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease

Ohwada, T., Sakamoto, T., Kanno, Y., Yokokawa, S., Amami, K., Nakazato, K., Takeishi, Y., & Watanabe, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212539 · Cited by 22 · see citing works

Consensus statement on the management of dyslipidaemias in adults

Béliard, S., Bonnet, F., Bouhanick, B., Bruckert, É., Cariou, B., Charrière, S., Durlach, V., Moulin, P., Valéro, R., & Vergès, B. L. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.07.033 · Cited by 21 · see citing works

Comprehensive assessment of lipoprotein subfraction profiles according to glucose metabolism status, and association with insulin resistance in subjects with early-stage impaired glucose metabolism

Lee, J.-E., Min, S. H., Lee, D., Oh, T. J., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. K. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.015 · Cited by 21 · see citing works

Dynamic path analysis – a useful tool to investigate mediation processes in clinical survival trials

Strohmaier, S., Røysland, K., Hoff, R., Borgan, Ø., Pedersen, T. R., & Aalen, O. O. (2015) · Statistics in Medicine · doi:10.1002/sim.6598 · Cited by 21 · see citing works

Relation of Combined Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes Mellitus

Bjornstad, P., Eckel, R. H., Pyle, L., Rewers, M., Maahs, D. M., & Snell‐Bergeon, J. K. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.07.020 · Cited by 20 · see citing works

Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988--1991 to 2005--2008

Ford, E. S., Li, C., & Sniderman, A. D. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-26 · Cited by 20 · see citing works

Assessing Cardiovascular Risk and Testing in Type 2 Diabetes

Saeed, A., & Ballantyne, C. M. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0831-4 · Cited by 20 · see citing works

Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences

Kathariya, G., Aggarwal, J., Garg, P., Singh, S., & Manzoor, S. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.05.008 · Cited by 19 · see citing works

Is the ratio of apoB/apoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores.

Hong, L.-F., Yan, X.-N., Fan, Y., Wu, Q., Luo, S.-H., Yang, B., & Li, J. (2015) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2015.04.012 · Cited by 19 · see citing works

Design of the Saitama Cardiometabolic Disease and Organ Impairment Study (SCDOIS): A Multidisciplinary Observational Epidemiological Study

Muneyuki, T., Suwa, K., Oshida, H., Takaoka, T., Kutsuma, A., Yoshida, T., Saito, M., Hori, Y., Kannno, Y., Kanda, E., et al. (2013) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2013.32022 · Cited by 18 · see citing works

MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population

Santos, P. C. J. L., de Oliveira, T. G. M., Lemos, P. A., Mill, J. G., Krieger, J. E., & Pereira, A. C. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-83 · Cited by 18 · see citing works

Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age

Hayashi, T., Araki, A., Kawashima, S., Sone, H., Watanabe, H., Ohrui, T., Yokote, K., Takemoto, M., Kubota, K., Noda, M., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-10 · Cited by 14 · see citing works

Impact of the Martin/Hopkins modified equation for estimating LDL-C on lipid target attainment in a high risk patient population

Cartier, L.-J., St-Cœur, S., Robin, A., Lagacé, M., & Douville, P. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.12.002 · Cited by 17 · see citing works

Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes

Bjornstad, P., Nguyen, N., Reinick, C. L., Maahs, D. M., Bishop, F. K., Clements, S. A., Snell‐Bergeon, J. K., Lieberman, R., Pyle, L. L., Daniels, S. R., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0693-9 · Cited by 16 · see citing works

Eucaloric diets enriched in palm olein, cocoa butter, and soybean oil did not differentially affect liver fat concentration in healthy participants: a 16-week randomized controlled trial.

Stonehouse, W., Sergi, D., Benassi-Evans, B., James-Martin, G., Johnson, N., Thompson, C. H., & Abeywardena, M. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa347 · Cited by 16 · see citing works

Dyslipidemia

Mancini, G. B. J., Hegele, R. A., & Leiter, L. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.032 · Cited by 15 · see citing works

Fatty acid regio-specificity of triacylglycerol molecules may affect plasma lipid responses to dietary fats—a randomised controlled cross-over trial

Stonehouse, W., Benassi-Evans, B., James-Martin, G., & Abeywardena, M. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0452-7 · Cited by 14 · see citing works

Fasting or Non-fasting Lipids for Atherosclerotic Cardiovascular Disease Risk Assessment and Treatment?

Rahman, F., Blumenthal, R. S., Jones, S. R., Martin, S. S., Gluckman, T. J., & Whelton, S. P. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0713-2 · Cited by 14 · see citing works

Plasma Lipoprotein(a) Levels and Atherosclerotic Renal Artery Stenosis in Hypertensive Patients

Catena, C., Colussi, G., Nait, F., Capobianco, F., & Sechi, L. A. (2015) · Kidney & Blood Pressure Research · doi:10.1159/000368492 · Cited by 12 · see citing works

The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy

Tani, S., Nagao, K., Kawauchi, K., Yagi, T., Atsumi, W., Matsuo, R., & Hirayama, A. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0238-z · Cited by 12 · see citing works

Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance

Liu, L., Li, Q., Yuan, Z., Zhao, M., Zhang, X., Zhang, H., Zheng, D., Xu, J., Gao, L., Guan, Q., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12837 · Cited by 12 · see citing works

Neutrophil gelatinase-associated lipocalin as diagnostic and prognostic tool for cardiovascular disease and heart failure

Iqbal, N., Choudhary, R., Chan, J., Wentworth, B. A., Higginbotham, E., & Maisel, A. S. (2013) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.763795 · Cited by 12 · see citing works

Non-HDL cholesterol, ApoB and LDL particle concentration in coronary heart disease risk prediction and treatment

Orringer, C. E. (2013) · Clinical Lipidology · doi:10.2217/clp.12.89 · Cited by 11 · see citing works

Discordance in Lipid Measurements: Can we Capitalize to Better Personalize Cardiovascular Risk Assessment and Treatment?

Cruz, D. E., Ahmed, H. M., Jones, S. R., Elshazly, M. B., & Martin, S. S. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0382-9 · Cited by 10 · see citing works

Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population

Martínez‐Hervás, S., Real, J. T., Priego, M. A., Carratalá, A., Sniderman, A. D., Carmena, R., & Ascaso, J. F. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02998.x · Cited by 10 · see citing works

Non-High-Density Lipoprotein Cholesterol and Coronary Artery Calcium Progression in a Multiethnic US Population

ZALAWADIYA, S. K., Veeranna, V., Panaich, S., Kottam, A. R., & Afonso, L. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.027 · Cited by 10 · see citing works

Low-density lipoprotein cholesterol levels in adults with type 2 diabetes: An alternative equation for accurate estimation and improved cardiovascular risk classification

Yeoh, E. C. K., Fang, S. C., Chang, S., Mun, S. L. K., Chi, L. S., Ying, Y. L., Wei, N. X., Tang, W. E., Ming, S. L. B., & Tavintharan, S. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114547703 · Cited by 10 · see citing works

Comparative cardiometabolic effects of fibrates and omega-3 fatty acids

Han, S. H., Oh, P. C., Lim, S. K., Eckel, R. H., & Koh, K. K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.223 · Cited by 9 · see citing works

Prediction of future development of cardiovascular disease with an equation to estimate apolipoprotein B

Hwang, Y., Park, C., Ahn, H. Y., & Cho, N. H. (2016) · Medicine · doi:10.1097/md.0000000000003644 · Cited by 9 · see citing works

The Importance of Non High Density Lipoprotein Cholesterol in Dyslipidaemia Management

Chowdhury, S., & Chowdhury, J. R. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000623 · Cited by 9 · see citing works

Screening for lipid disorders

Bell, D. A., Hooper, A. J., Robert, B., Edwards, G., BOCKXMEER, F. M. V., Watts, G. F., & Burnett, J. R. (2011) · Pathology · doi:10.1097/pat.0b013e32834f90fe · Cited by 9 · see citing works

Non-HDL Cholesterol and Atherosclerotic Cardiovascular Disease.

Puri, R., Mehta, V., Iyengar, S. S., Narasingan, S. N., Duell, P. B., Sattur, G. B., Vijayaraghavan, K., Mohan, J. C., Wangnoo, S. K., Dalal, J. J., et al. (2020) · PubMed · Cited by 7 · see citing works

Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese south indian men: an indication for increased cardiovascular risk

Ikkruthi, S., Rajappa, M., Nandeesha, H., Satheesh, S., Sundar, I., Ananthanarayanan, P., & Harichandrakumar, K. (2013) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.100.2013.017 · Cited by 8 · see citing works

Non-high-density Lipoprotein Cholesterol Levels in Japanese Obese Boys with Metabolic Syndrome

Saito, E., Okada, T., Abe, Y., Kazama, M., Yonezawa, R., Kuromori, Y., Iwata, F., & Hara, M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.30692 · Cited by 8 · see citing works

LDL-Cholesterol Targets After the ACC/AHA 2013 Guidelines

Ben‐Yehuda, O., & DeMaria, A. N. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.020 · Cited by 8 · see citing works

Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine

Kenkre, J. S., Mazaheri, T., Neely, R. D. G., Soran, H., Datta, D. B. N., Penson, P. E., Downie, P., Yates, A. M., Hayden, K., Patel, M., et al. (2025) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632251315303 · Cited by 8 · see citing works

ApoB, non-HDL-C, and LDL-C Are More Prominent in Retinal Artery Occlusion Compared to Retinal Vein Occlusion

Chen, T., Li, Y., Wang, Y., Li, X., Wan, Y., & Xiao, X. (2023) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2023.2173245 · Cited by 7 · see citing works

Association of non-HDL cholesterol with plaque burden and composition of culprit lesion in acute coronary syndrome. An intravascular ultrasound-virtual histology study

Sreenivas Reddy, S., Raghavendra Rao, K., Kashyap, J. R., Kadiyala, V., Kumar, S., Dash, D., Uppal, L., Kaur, J., Kaur, M., Reddy, H., et al. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.10.004 · Cited by 7 · see citing works

Perspectives on a new prescription omega-3 fatty acid, icosapent ethyl, for hypertriglyceridemia

Jacobson, T. A. (2014) · Clinical Lipidology · doi:10.2217/clp.14.10 · Cited by 6 · see citing works

Apolipoproteins for cardiovascular risk assessment.

Chang, J. G., Paulson, C. P., & Smith, R. F. (2014) · PubMed · Cited by 6 · see citing works

Another Step Forward in Refining Risk Stratification

Milani, R. V., & Lavie, C. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.036 · Cited by 6 · see citing works

Impact of Adjunctive Cilostazol Therapy Versus High Maintenance Dose of Clopidogrel in Suboptimal Responders With Diabetes Mellitus

Ferreiro, J. L., Ueno, M., Desai, B., Capranzano, P., Capodanno, D., & Angiolillo, D. J. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.04.007 · Cited by 8 · see citing works

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659 · see citing works

NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL VERSUS APOLIPOPROTEIN B AS PREDICTORS FOR CORONARY HEART DISEASE

Aggarwal, J., Reddy, S., & Nagtilak, S. (2014) · International Journal of Pharma and Bio Sciences

Why is non−high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?

Sniderman, A. D., McQueen, M. J., Contois, J. H., Williams, K., & Furberg, C. D. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.03.005 · Cited by 88 · see citing works

ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease

Sniderman, A. D. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab140 · Cited by 28 · see citing works